BioSpace News Archive

Kyros Law Offices is alerting individuals that have suffered serious side effects from taking Invokana that it is investigating filing legal claims seeking compensation for their injuries.

The SanBio Groupn hereby announces that the US-based phase 1/2a clinical trial of SB623 for the treatment of chronic motor deficit from ischemic stroke

Agency is taking additional steps to advance the development of new FDA-approved treatments for opioid dependence and encourage their more widespread use [14-June-2018] SILVER SPRING, Md., June 14, 2018 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual

Zimmer Biomet Holdings, Inc. announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2018.

Following the great success of the First International NASH Day, The NASH Education Program announces second edition will take place in June 2019

Hanger, Inc. announced the filing of its Quarterly Report on Form 10-Q for the three months ended March 31, 2018 with the Securities and Exchange Commission.

Med Associates, Inc. processes claims for medical providers located in and around Albany, NY.

African Union and Organisation of African First Ladies Against HIV/AIDS call for immediate prioritisation of accessible health services tailored to the needs of children with or at risk of HIV

The board of directors of AbbVie Inc. declared a quarterly cash dividend of $0.96 per share.

The American Academy of Ophthalmology reiterated its long-standing guidance for patients considering LASIK vision correction surgery.